| muscle system process | GO:0003012 | 141 | 0.943 | |
| muscle contraction | GO:0006936 | 101 | 0.900 | |
| striated muscle cell development | GO:0055002 | 125 | 0.896 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.882 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.867 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.848 | |
| skeletal muscle thin filament assembly | GO:0030240 | 2 | 0.847 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.835 | |
| sarcomere organization | GO:0045214 | 24 | 0.803 | |
| cardiac cell development | GO:0055006 | 41 | 0.789 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.759 | Yeast |
| actin filament organization | GO:0007015 | 113 | 0.751 | Yeast |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.702 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.686 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.686 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.651 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.618 | |
| organelle assembly | GO:0070925 | 177 | 0.590 | |
| muscle cell development | GO:0055001 | 133 | 0.571 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.563 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.562 | |
| regulation of cell motility | GO:2000145 | 236 | 0.542 | Mouse |
| skeletal myofibril assembly | GO:0014866 | 4 | 0.502 | |
| actin filament based movement | GO:0030048 | 23 | 0.481 | |
| muscle tissue development | GO:0060537 | 308 | 0.469 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.445 | |
| lung development | GO:0030324 | 164 | 0.433 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.423 | |
| cardiac myofibril assembly | GO:0055003 | 12 | 0.419 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.417 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.408 | |
| myofibril assembly | GO:0030239 | 34 | 0.392 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.383 | |
| muscle fiber development | GO:0048747 | 76 | 0.374 | |
| regulation of system process | GO:0044057 | 200 | 0.371 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.366 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.359 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.354 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.346 | |
| vasoconstriction | GO:0042310 | 27 | 0.343 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.342 | |
| circulatory system process | GO:0003013 | 197 | 0.334 | |
| negative regulation of phagocytosis | GO:0050765 | 4 | 0.315 | Mouse |
| epithelial cell development | GO:0002064 | 159 | 0.308 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.306 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.295 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.285 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.280 | |
| cell adhesion | GO:0007155 | 329 | 0.276 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.275 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.257 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.254 | |
| heart morphogenesis | GO:0003007 | 178 | 0.248 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.244 | |
| elastic fiber assembly | GO:0048251 | 4 | 0.242 | |
| myosin filament organization | GO:0031033 | 3 | 0.229 | |
| response to growth factor | GO:0070848 | 198 | 0.227 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.216 | |
| digestive system development | GO:0055123 | 200 | 0.211 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.209 | |
| wound healing | GO:0042060 | 157 | 0.205 | Mouse |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.204 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.203 | |
| blood circulation | GO:0008015 | 195 | 0.202 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.201 | |
| mapk cascade | GO:0000165 | 281 | 0.200 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.197 | |
| regulation of cell migration | GO:0030334 | 219 | 0.196 | Mouse |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.194 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.189 | Mouse |
| respiratory tube development | GO:0030323 | 167 | 0.188 | |
| regulation of cell growth | GO:0001558 | 91 | 0.188 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.188 | |
| cardiac chamber development | GO:0003205 | 108 | 0.187 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.185 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.185 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.184 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.181 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.181 | |
| regionalization | GO:0003002 | 337 | 0.179 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.170 | |
| regulation of tube size | GO:0035150 | 57 | 0.164 | |
| respiratory system development | GO:0060541 | 190 | 0.164 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.163 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.162 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.162 | |
| heart process | GO:0003015 | 94 | 0.159 | |
| camera type eye development | GO:0043010 | 266 | 0.159 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.156 | |
| mesenchyme development | GO:0060485 | 152 | 0.155 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.154 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.154 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.151 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.150 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.148 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.148 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.148 | |
| microtubule based process | GO:0007017 | 236 | 0.145 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.144 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.144 | |
| salivary gland morphogenesis | GO:0007435 | 33 | 0.142 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.141 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.140 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.138 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.138 | |
| heart contraction | GO:0060047 | 93 | 0.137 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.137 | |
| molting cycle | GO:0042303 | 90 | 0.135 | |
| striated muscle contraction | GO:0006941 | 45 | 0.134 | |
| myosin filament assembly | GO:0031034 | 2 | 0.132 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.132 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.129 | |
| cell fate commitment | GO:0045165 | 210 | 0.128 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.128 | |
| protein maturation | GO:0051604 | 176 | 0.127 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.125 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.124 | |
| angiogenesis | GO:0001525 | 201 | 0.122 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.122 | |
| muscle cell fate specification | GO:0042694 | 1 | 0.119 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.117 | |
| endocytosis | GO:0006897 | 168 | 0.116 | Mouse |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.115 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.115 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.114 | |
| myotube differentiation | GO:0014902 | 105 | 0.111 | |
| vascular smooth muscle contraction | GO:0014829 | 5 | 0.111 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.107 | |
| transmembrane transport | GO:0055085 | 412 | 0.106 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.105 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.105 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.105 | |
| skin development | GO:0043588 | 220 | 0.103 | |
| stem cell differentiation | GO:0048863 | 268 | 0.102 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.100 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.099 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.099 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.099 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.098 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.097 | |
| regulation of anagen | GO:0051884 | 1 | 0.097 | |
| protein catabolic process | GO:0030163 | 221 | 0.097 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.097 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.096 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.096 | |
| cardiac muscle fiber development | GO:0048739 | 4 | 0.096 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.095 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.094 | |
| gland development | GO:0048732 | 330 | 0.093 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.093 | |
| neuron projection extension | GO:1990138 | 64 | 0.092 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.092 | |
| fat cell differentiation | GO:0045444 | 160 | 0.089 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.088 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.086 | |
| chemotaxis | GO:0006935 | 247 | 0.085 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.084 | |
| axon guidance | GO:0007411 | 141 | 0.084 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.084 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.083 | |
| response to inorganic substance | GO:0010035 | 96 | 0.083 | |
| neuromuscular process | GO:0050905 | 99 | 0.082 | |
| cell growth | GO:0016049 | 130 | 0.081 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.081 | |
| maintenance of location | GO:0051235 | 89 | 0.080 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.080 | |
| cation transport | GO:0006812 | 399 | 0.080 | |
| tissue homeostasis | GO:0001894 | 115 | 0.079 | |
| negative regulation of growth | GO:0045926 | 99 | 0.079 | |
| digestive tract development | GO:0048565 | 190 | 0.078 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.078 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.077 | |
| amide transport | GO:0042886 | 138 | 0.077 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.077 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.076 | |
| blood coagulation | GO:0007596 | 76 | 0.076 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.075 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.075 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.075 | |
| ossification | GO:0001503 | 216 | 0.075 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.075 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.074 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.074 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.074 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.073 | |
| glucose homeostasis | GO:0042593 | 128 | 0.073 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.073 | |
| bone morphogenesis | GO:0060349 | 78 | 0.073 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.072 | |
| bone development | GO:0060348 | 120 | 0.072 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.072 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.071 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.071 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.070 | |
| renal system development | GO:0072001 | 225 | 0.070 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.070 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.069 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.069 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.069 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.069 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.069 | |
| placenta development | GO:0001890 | 140 | 0.068 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.068 | |
| apoptotic process involved in morphogenesis | GO:0060561 | 25 | 0.068 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.067 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.066 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.066 | |
| activation of immune response | GO:0002253 | 138 | 0.065 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.065 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 41 | 0.065 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.065 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.064 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.064 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.064 | |
| axonogenesis | GO:0007409 | 274 | 0.064 | |
| atp catabolic process | GO:0006200 | 55 | 0.063 | |
| substrate dependent cell migration | GO:0006929 | 18 | 0.063 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.063 | |
| mesoderm development | GO:0007498 | 100 | 0.062 | |
| regulation of defense response | GO:0031347 | 233 | 0.062 | |
| midgut development | GO:0007494 | 4 | 0.062 | |
| response to metal ion | GO:0010038 | 47 | 0.061 | |
| apical constriction | GO:0003383 | 4 | 0.061 | |
| positive regulation of cell growth | GO:0030307 | 33 | 0.061 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.061 | |
| positive regulation of thymocyte migration | GO:2000412 | 2 | 0.060 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.060 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.060 | |
| gonad development | GO:0008406 | 141 | 0.060 | |
| regulation of cell size | GO:0008361 | 72 | 0.059 | |
| negative regulation of phospholipase activity | GO:0010519 | 4 | 0.059 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.059 | |
| epithelial tube formation | GO:0072175 | 130 | 0.059 | |
| regulation of cell shape | GO:0008360 | 39 | 0.058 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.058 | |
| organelle localization | GO:0051640 | 179 | 0.058 | |
| embryonic placenta development | GO:0001892 | 98 | 0.058 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.057 | |
| regulation of organ growth | GO:0046620 | 61 | 0.057 | |
| segmentation | GO:0035282 | 93 | 0.056 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.056 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.055 | |
| stem cell proliferation | GO:0072089 | 117 | 0.055 | |
| developmental cell growth | GO:0048588 | 84 | 0.055 | |
| immune effector process | GO:0002252 | 321 | 0.055 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.055 | |
| ventricular cardiac muscle cell development | GO:0055015 | 11 | 0.055 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.055 | |
| positive regulation of growth | GO:0045927 | 104 | 0.054 | |
| regulation of actin filament length | GO:0030832 | 45 | 0.054 | |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.054 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.054 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.053 | |
| neuron recognition | GO:0008038 | 25 | 0.053 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.053 | |
| tissue remodeling | GO:0048771 | 102 | 0.053 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.052 | |
| hindbrain development | GO:0030902 | 128 | 0.052 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.052 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.052 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.052 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.051 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.051 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.051 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.051 | |
| lipid localization | GO:0010876 | 126 | 0.051 | |
| cellular homeostasis | GO:0019725 | 240 | 0.051 | |
| fourth ventricle development | GO:0021592 | 2 | 0.050 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.050 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.050 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.050 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.050 | |
| multicellular organism growth | GO:0035264 | 161 | 0.050 | |
| mesangial cell differentiation | GO:0072007 | 4 | 0.049 | |
| response to oxygen levels | GO:0070482 | 62 | 0.049 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.049 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.048 | |
| t cell activation | GO:0042110 | 289 | 0.048 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.048 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.047 | |
| regulation of ossification | GO:0030278 | 112 | 0.047 | |
| forebrain development | GO:0030900 | 302 | 0.047 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.047 | |
| negative regulation of bone trabecula formation | GO:1900155 | 1 | 0.047 | |
| regulation of cardiac muscle tissue growth | GO:0055021 | 26 | 0.046 | |
| stem cell development | GO:0048864 | 219 | 0.046 | |
| positive regulation of eosinophil migration | GO:2000418 | 2 | 0.046 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.046 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.046 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.046 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.045 | |
| regulation of heart growth | GO:0060420 | 31 | 0.045 | |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 47 | 0.045 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.045 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.044 | |
| oocyte axis specification | GO:0007309 | 2 | 0.044 | |
| regulation of phagocytosis | GO:0050764 | 33 | 0.044 | Mouse |
| ovulation cycle | GO:0042698 | 59 | 0.044 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.044 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.044 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.044 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.043 | |
| ventricular cardiac muscle cell differentiation | GO:0055012 | 17 | 0.043 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.043 | |
| cell division | GO:0051301 | 120 | 0.043 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.043 | |
| long chain fatty acid import | GO:0044539 | 2 | 0.042 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.042 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.042 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.042 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.042 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.042 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.041 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.041 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.041 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.040 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.040 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.040 | |
| polarity specification of proximal distal axis | GO:0010085 | 2 | 0.040 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.040 | |
| cilium morphogenesis | GO:0060271 | 102 | 0.040 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.040 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.039 | |
| wnt signaling pathway calcium modulating pathway | GO:0007223 | 2 | 0.039 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.039 | |
| negative regulation of protein depolymerization | GO:1901880 | 21 | 0.039 | |
| oocyte construction | GO:0007308 | 2 | 0.039 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.039 | |
| maintenance of cell number | GO:0098727 | 3 | 0.039 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.039 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.039 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.038 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.038 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.038 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.038 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.038 | |
| positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090100 | 43 | 0.038 | |
| regulation of protein localization | GO:0032880 | 231 | 0.038 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.038 | |
| epidermis development | GO:0008544 | 187 | 0.037 | |
| glucose metabolic process | GO:0006006 | 92 | 0.037 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.037 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.037 | |
| urogenital system development | GO:0001655 | 261 | 0.037 | |
| response to drug | GO:0042493 | 75 | 0.037 | |
| peripheral nervous system axon regeneration | GO:0014012 | 2 | 0.036 | |
| cytokinesis | GO:0000910 | 17 | 0.036 | |
| tubulin complex assembly | GO:0007021 | 2 | 0.036 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.036 | |
| regulation of ventricular cardiac muscle cell membrane depolarization | GO:0060373 | 2 | 0.036 | |
| negative regulation of b cell receptor signaling pathway | GO:0050859 | 4 | 0.036 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.036 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.036 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.036 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.036 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.036 | |
| coagulation | GO:0050817 | 78 | 0.036 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.036 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.036 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.035 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.035 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.035 | |
| inflammatory response | GO:0006954 | 244 | 0.035 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.035 | |
| endomembrane system organization | GO:0010256 | 147 | 0.035 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.035 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.035 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.035 | |
| protein processing | GO:0016485 | 163 | 0.034 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.034 | Mouse |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.034 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.034 | |
| regulation of protein processing | GO:0070613 | 96 | 0.034 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.034 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.033 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.033 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.033 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 3 | 0.033 | |
| limb development | GO:0060173 | 166 | 0.033 | |
| response to hypoxia | GO:0001666 | 58 | 0.033 | |
| response to calcium ion | GO:0051592 | 20 | 0.033 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.033 | |
| nephric duct formation | GO:0072179 | 4 | 0.033 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.033 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.032 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.032 | |
| activation of mapk activity | GO:0000187 | 59 | 0.032 | |
| response to fibroblast growth factor | GO:0071774 | 47 | 0.032 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.032 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.032 | |
| macromolecular complex disassembly | GO:0032984 | 43 | 0.032 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.032 | |
| limb morphogenesis | GO:0035108 | 149 | 0.032 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.032 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.032 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.032 | |
| response to nutrient levels | GO:0031667 | 109 | 0.031 | |
| glomerulus development | GO:0032835 | 40 | 0.031 | |
| bone resorption | GO:0045453 | 38 | 0.031 | |
| positive regulation of mitotic cell cycle phase transition | GO:1901992 | 17 | 0.031 | |
| peptide transport | GO:0015833 | 133 | 0.031 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.031 | |
| rhythmic process | GO:0048511 | 174 | 0.031 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.031 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.030 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.030 | |
| protein polymerization | GO:0051258 | 57 | 0.030 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.030 | |
| positive regulation of plasminogen activation | GO:0010756 | 2 | 0.030 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.030 | |
| establishment or maintenance of apical basal cell polarity | GO:0035088 | 21 | 0.030 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.030 | |
| tendon cell differentiation | GO:0035990 | 4 | 0.030 | |
| regulation of axon extension | GO:0030516 | 43 | 0.030 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.029 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.029 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.029 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.029 | |
| regulation of binding | GO:0051098 | 111 | 0.029 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.029 | |
| establishment or maintenance of bipolar cell polarity | GO:0061245 | 21 | 0.029 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.029 | |
| protein localization to membrane | GO:0072657 | 108 | 0.029 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.029 | |
| acetylcholine transport | GO:0015870 | 2 | 0.029 | |
| feeding behavior | GO:0007631 | 62 | 0.029 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.029 | |
| hair cycle | GO:0042633 | 90 | 0.028 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.028 | |
| salivary gland development | GO:0007431 | 37 | 0.028 | |
| potassium ion transport | GO:0006813 | 52 | 0.028 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.028 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.028 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.028 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.028 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.028 | |
| positive regulation of smoothened signaling pathway | GO:0045880 | 23 | 0.028 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.028 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.028 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.028 | |
| skeletal system development | GO:0001501 | 356 | 0.028 | |
| neuron projection guidance | GO:0097485 | 141 | 0.028 | |
| tube formation | GO:0035148 | 140 | 0.028 | |
| oxidation reduction process | GO:0055114 | 342 | 0.028 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.028 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.028 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.028 | |
| regulation of exit from mitosis | GO:0007096 | 1 | 0.028 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.028 | |
| non canonical wnt signaling pathway via jnk cascade | GO:0038031 | 3 | 0.027 | |
| skin morphogenesis | GO:0043589 | 38 | 0.027 | |
| regulation of secretion | GO:0051046 | 274 | 0.027 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.027 | |
| hormone secretion | GO:0046879 | 128 | 0.027 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.027 | |
| hemostasis | GO:0007599 | 78 | 0.027 | |
| amine metabolic process | GO:0009308 | 45 | 0.027 | |
| regulation of synapse assembly | GO:0051963 | 29 | 0.027 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.027 | |
| placenta blood vessel development | GO:0060674 | 31 | 0.027 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.027 | |
| extracellular structure organization | GO:0043062 | 148 | 0.027 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.027 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.027 | |
| establishment of t cell polarity | GO:0001768 | 2 | 0.027 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.027 | |
| mesendoderm development | GO:0048382 | 3 | 0.027 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.027 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.026 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.026 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.026 | |
| lipid transport | GO:0006869 | 98 | 0.026 | |
| collagen fibril organization | GO:0030199 | 32 | 0.026 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.026 | |
| female sex differentiation | GO:0046660 | 84 | 0.026 | |
| formation of organ boundary | GO:0010160 | 1 | 0.026 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.026 | |
| regulation of protein transport | GO:0051223 | 163 | 0.026 | |
| atrial ventricular junction remodeling | GO:0003294 | 2 | 0.026 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.026 | |
| neuron death | GO:0070997 | 154 | 0.025 | |
| protein activation cascade | GO:0072376 | 19 | 0.025 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.025 | |
| appendage development | GO:0048736 | 166 | 0.025 | |
